NCT05683730 Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease Status RECRUITING Phase NA
NCT05652491 The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease Status WITHDRAWN Phase N/A
NCT05626088 A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05626023 A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT05596422 A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase N/A
NCT05509777 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease Status RECRUITING Phase PHASE3
NCT05442567 A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status RECRUITING Phase PHASE3
NCT05428345 A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea Status RECRUITING Phase N/A
NCT05394805 A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD) Status COMPLETED Phase N/A
NCT05384080 A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland Status COMPLETED Phase N/A
NCT05242471 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05242458 A Study of Ustekinumab Treatment in Children With Crohn's Disease Status COMPLETED Phase N/A
NCT05088369 Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 Status COMPLETED Phase PHASE1
NCT05078879 Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency Status COMPLETED Phase PHASE1
NCT05068284 A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT05057273 Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease Status WITHDRAWN Phase PHASE2